D-Ribose
Natural health product licensed in Canada
- Licence holder
- Biotics Research Corporation
- NPN or DIN-HM
- 80042552
- Status
- Active licence
- Licence date
- 30 May 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ribo-2,3,4,5-tétrahydroxyvaléraldéhyde, D- Source : Ribose | 2.5 g | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Cuillère à thé | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Athletic Support. Workout/Exercise Supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not take if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have been diagnosed with hypoglycemia or have diabetes. May cause mild stomach discomfort. Consult a health care practitioner prior to use if you have been diagnosed with a chronic disease. Consult a health care practitioner prior to use if you are following a low protein diet. Consult a health care practitioner prior to use if you have a kidney disorder. May result in weight gain.
Source
Official Health Canada record, licence 80042552
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.